Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.

In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination.

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...

The prescription device is a wearable belt that includes a motor designed to transmit low amplitude, high frequency vibration to the spine and hips.

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

The approach could mean no COVID boosters will be approved in time for next winter’s respiratory disease season, Makary has warned in earlier interviews.

The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

Tepylute is indicated for the treatment of adenocarcinoma of the breast or ovary . It is now supplied as a multiple-dose vial ...

HealthDay News — North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge, the Associated Press is reporting.

In the past, longer trips were seen as a way to group several inspections into one trip, saving money and reducing the strain of traveling.